These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pretreatment of mice with rifampicin prolongs survival of endotoxic shock by modulating the levels of inflammatory cytokines. An N; Song Y; Zhang X; Ci X; Li H; Cao Y; Zhang M; Cui J; Deng X Immunopharmacol Immunotoxicol; 2008; 30(3):437-46. PubMed ID: 18618311 [TBL] [Abstract][Full Text] [Related]
10. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages. Grinsell M; Weinhold LC; Cutler JE; Han Y; Kozel TR J Infect Dis; 2001 Aug; 184(4):479-87. PubMed ID: 11471106 [TBL] [Abstract][Full Text] [Related]
12. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum. Li RK; Mitchell TG J Med Vet Mycol; 1997; 35(5):327-34. PubMed ID: 9402525 [TBL] [Abstract][Full Text] [Related]
13. Foenumoside B isolated from Lysimachia foenum-graecum extract suppresses LPS-induced inflammatory response via NF-κB/AP-1 inactivation in murine macrophages and in endotoxin-induced shock model. Choi HE; Kwak HJ; Kim SK; Cheon HG Eur J Pharmacol; 2018 Aug; 832():120-128. PubMed ID: 29782861 [TBL] [Abstract][Full Text] [Related]
14. Regulation of macrophage activation and septic shock susceptibility via p21(WAF1/CIP1). Trakala M; Arias CF; García MI; Moreno-Ortiz MC; Tsilingiri K; Fernández PJ; Mellado M; Díaz-Meco MT; Moscat J; Serrano M; Martínez-A C; Balomenos D Eur J Immunol; 2009 Mar; 39(3):810-9. PubMed ID: 19224635 [TBL] [Abstract][Full Text] [Related]
15. Arvelexin from Brassica rapa suppresses NF-κB-regulated pro-inflammatory gene expression by inhibiting activation of IκB kinase. Shin JS; Noh YS; Lee YS; Cho YW; Baek NI; Choi MS; Jeong TS; Kang E; Chung HG; Lee KT Br J Pharmacol; 2011 Sep; 164(1):145-58. PubMed ID: 21434881 [TBL] [Abstract][Full Text] [Related]
16. Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway. Chiapello LS; Baronetti JL; Garro AP; Spesso MF; Masih DT Int Immunol; 2008 Dec; 20(12):1527-41. PubMed ID: 18927317 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Mukherjee S; Lee S; Mukherjee J; Scharff MD; Casadevall A Infect Immun; 1994 Mar; 62(3):1079-88. PubMed ID: 8112842 [TBL] [Abstract][Full Text] [Related]
19. Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis. Tissi L; Puliti M; Bistoni F; Mosci P; Kozel TR; Vecchiarelli A Infect Immun; 2004 Nov; 72(11):6367-72. PubMed ID: 15501766 [TBL] [Abstract][Full Text] [Related]
20. A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production. Monari C; Bevilacqua S; Piccioni M; Pericolini E; Perito S; Calvitti M; Bistoni F; Kozel TR; Vecchiarelli A J Immunol; 2009 Jul; 183(1):191-200. PubMed ID: 19542430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]